I can tell you are excited.
This Phase 1 safety study is to be performed on "12 Princess Alexandra Hospital patients" only.
250k should be plenty.
NB: They've been smart this time with the Phase 1 participant selection. Whereas the HSV study used healthy volunteers, this study will use "patients with head and neck cancer who have had successful chemotherapy and radiation treatment" - i.e. a relevant population
Ahz vax in news, page-14
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M | |||
| Open | High | Low | Value | Volume |
| $18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 554 | 1 |
View Market Depth
| Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |